Cargando…
The Uro-oncology Patient and Vaccination Against SARS-CoV-2
As of April 13, 2021, 137 million cases of COVID-19 and 2.95 million deaths have been reported worldwide. On December 21, 2020, the Pfizer-BioNTech vaccine was approved for use in the European Union, with efficacy of 95% protection against COVID-19 infection. Several other vaccines are at different...
Autores principales: | Rodriguez Socarrás, Moises, Gómez Rivas, Juan, Teoh, Jeremy Yuen-Chun, Puente, Javier, Moschini, Marco, Moreno-Sierra, Jesús |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156907/ https://www.ncbi.nlm.nih.gov/pubmed/34075362 http://dx.doi.org/10.1016/j.euros.2021.05.007 |
Ejemplares similares
-
External Validation of the ASSURE Model for Predicting Oncological Outcomes After Resection of High-risk Renal Cell Carcinoma (RESCUE Study: UroCCR 88)
por: Khene, Zine-Eddine, et al.
Publicado: (2021) -
Robotics in uro-oncologic surgery
por: De Lorenzis, Elisa, et al.
Publicado: (2013) -
Positron emission tomography in uro-oncology
por: Hain, S F
Publicado: (2005) -
Postoperative pulmonary complications in robot-assisted uro-oncological surgeries: Our experience in a tertiary cancer care centre
por: Pramanik, Monotosh, et al.
Publicado: (2020) -
The potential impact of previous exposure to SARS or MERS on control of the COVID-19 pandemic
por: Huang, Junjie, et al.
Publicado: (2020)